Therapeutic Modalities, Roche Pharma Research and Early Development, Roche Innovation Center Copenhagen, DK-2970 Hørsholm, Denmark.
Department of Biotechnology and Biomedicine, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.
Nucleic Acids Res. 2018 Jun 20;46(11):5366-5380. doi: 10.1093/nar/gky397.
Antisense oligonucleotides that are dependent on RNase H for cleavage and subsequent degradation of complementary RNA are being developed as therapeutics. Besides the intended RNA target, such oligonucleotides may also cause degradation of unintended RNA off-targets by binding to partially complementary target sites. Here, we characterized the global effects on the mouse liver transcriptome of four oligonucleotides designed as gapmers, two targeting Apob and two targeting Pcsk9, all in different regions on their respective intended targets. This study design allowed separation of intended- and off-target effects on the transcriptome for each gapmer. Next, we used sequence analysis to identify possible partially complementary binding sites among the potential off-targets, and validated these by measurements of melting temperature and RNase H-cleavage rates. Generally, our observations were as expected in that fewer mismatches or bulges in the gapmer/transcript duplexes resulted in a higher chance of those duplexes being effective substrates for RNase H. Follow-up experiments in mice and cells show, that off-target effects can be mitigated by ensuring that gapmers have minimal sequence complementarity to any RNA besides the intended target, and that they do not have exaggerated binding affinity to the intended target.
依赖 RNase H 切割和随后降解互补 RNA 的反义寡核苷酸正在被开发为治疗药物。除了预期的 RNA 靶标外,这些寡核苷酸还可能通过与部分互补的靶标结合而导致非预期的 RNA 脱靶降解。在这里,我们描述了四种设计为 gapmer 的寡核苷酸对小鼠肝脏转录组的全局影响,其中两种靶向 Apob,两种靶向 Pcsk9,它们在各自靶标上的不同区域。这种研究设计允许为每个 gapmer 分离靶标和脱靶对转录组的影响。接下来,我们使用序列分析来识别潜在脱靶物中的可能部分互补结合位点,并通过测量熔点和 RNase H 切割率来验证这些位点。通常,我们的观察结果与预期一致,即 gapmer/转录物双链体中的错配或凸起越少,这些双链体成为 RNase H 的有效底物的机会就越高。在小鼠和细胞中的后续实验表明,可以通过确保 gapmer 与除预期靶标之外的任何 RNA 具有最小的序列互补性,并且它们对预期靶标没有夸张的结合亲和力,来减轻脱靶效应。